{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:13:48Z","timestamp":1772165628324,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04499-2","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T06:05:45Z","timestamp":1766037945000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aspirin reduces short-term mortality risk in critically ill patients with liver cirrhosis: a propensity-score matched retrospective analysis using the MIMIC-IV database"],"prefix":"10.1186","volume":"26","author":[{"given":"Yu","family":"Yi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinghua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yawen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"4499_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70:151\u201371. https:\/\/doi.org\/10.1016\/j.jhep.2018.09.014.","journal-title":"J Hepatol"},{"key":"4499_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cgh.2021.10.036","volume":"21","author":"C Griffin","year":"2023","unstructured":"Griffin C, Agbim U, Ramani A, Shankar N, Kanwal F, Asrani SK. Underestimation of cirrhosis-related mortality in the medicare eligible population, 1999\u20132018. Clin Gastroenterol Hepatol. 2023;21:223-225.e3. https:\/\/doi.org\/10.1016\/j.cgh.2021.10.036.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4499_CR3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023;79:516\u201337. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.017.","journal-title":"J Hepatol"},{"key":"4499_CR4","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jhep.2020.11.042","volume":"75","author":"P Jepsen","year":"2021","unstructured":"Jepsen P, Younossi ZM. The global burden of cirrhosis: a review of disability-adjusted life-years lost and unmet needs. J Hepatol. 2021;75:S3\u201313. https:\/\/doi.org\/10.1016\/j.jhep.2020.11.042.","journal-title":"J Hepatol"},{"key":"4499_CR5","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.14309\/ajg.0000000000001292","volume":"116","author":"C Ma","year":"2021","unstructured":"Ma C, Qian AS, Nguyen NH, Stukalin I, Congly SE, Shaheen AA, et al. Trends in the economic burden of chronic liver diseases and cirrhosis in the united states: 1996\u20132016. Am J Gastroenterol. 2021;116:2060\u20137. https:\/\/doi.org\/10.14309\/ajg.0000000000001292.","journal-title":"Am J Gastroenterol"},{"key":"4499_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1478-3231.2011.02517.x","volume":"32","author":"KM Fleming","year":"2012","unstructured":"Fleming KM, Aithal GP, Card TR, West J. All-cause mortality in people with cirrhosis compared with the general population: a population\u2010based cohort study. Liver Int. 2012;32:79\u201384. https:\/\/doi.org\/10.1111\/j.1478-3231.2011.02517.x.","journal-title":"Liver Int"},{"key":"4499_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","volume":"5","author":"SG Sepanlou","year":"2020","unstructured":"Sepanlou SG, Safiri S, Bisignano C, Ikuta KS, Merat S, Saberifiroozi M, et al. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2020;5:245\u201366. https:\/\/doi.org\/10.1016\/S2468-1253(19)30349-8.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"4499_CR8","doi-asserted-by":"publisher","first-page":"6292","DOI":"10.1073\/pnas.1804000116","volume":"116","author":"MM Gilligan","year":"2019","unstructured":"Gilligan MM, Gartung A, Sulciner ML, Norris PC, Sukhatme VP, Bielenberg DR, et al. Aspirin-triggered proresolving mediators stimulate resolution in cancer. Proc Natl Acad Sci USA. 2019;116:6292\u20137. https:\/\/doi.org\/10.1073\/pnas.1804000116.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4499_CR9","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1038\/onc.2017.73","volume":"36","author":"H Chen","year":"2017","unstructured":"Chen H, Cai W, Chu ESH, Tang J, Wong C-C, Wong SH, et al. Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice. Oncogene. 2017;36:4415\u201326. https:\/\/doi.org\/10.1038\/onc.2017.73.","journal-title":"Oncogene"},{"key":"4499_CR10","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1136\/gut.2008.157420","volume":"58","author":"Y-H Paik","year":"2009","unstructured":"Paik Y-H, Kim JK, Lee JI, Kang SH, Kim DY, An SH, et al. Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats. Gut. 2009;58:1517\u201327. https:\/\/doi.org\/10.1136\/gut.2008.157420.","journal-title":"Gut"},{"key":"4499_CR11","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1053\/j.gastro.2014.08.038","volume":"147","author":"S Yoshida","year":"2014","unstructured":"Yoshida S, Ikenaga N, Liu SB, Peng Z-W, Chung J, Sverdlov DY, et al. Extrahepatic platelet-derived growth factor-\u03b2, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice. Gastroenterology. 2014;147:1378\u201392. https:\/\/doi.org\/10.1053\/j.gastro.2014.08.038.","journal-title":"Gastroenterology"},{"key":"4499_CR12","doi-asserted-by":"publisher","first-page":"1111371","DOI":"10.3389\/fmed.2023.1111371","volume":"10","author":"Y Ren","year":"2023","unstructured":"Ren Y, Zhao Y, Yang X, Shen C, Luo H. Application of low dose aspirin in pre-eclampsia. Front Med. 2023;10:1111371. https:\/\/doi.org\/10.3389\/fmed.2023.1111371.","journal-title":"Front Med"},{"key":"4499_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.718896","volume":"8","author":"TM Kronborg","year":"2021","unstructured":"Kronborg TM, Ytting H, Hobolth L, M\u00f8ller S, Kimer N. Novel anti-inflammatory treatments in cirrhosis. A literature-based study. Front Med. 2021;8:718896. https:\/\/doi.org\/10.3389\/fmed.2021.718896.","journal-title":"Front Med"},{"key":"4499_CR14","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1093\/bjs\/znad231","volume":"110","author":"D Shah","year":"2023","unstructured":"Shah D, Di Re A, Toh JWT. Aspirin chemoprevention in colorectal cancer: network meta-analysis of low, moderate, and high doses. Br J Surg. 2023;110:1691\u2013702. https:\/\/doi.org\/10.1093\/bjs\/znad231.","journal-title":"Br J Surg"},{"key":"4499_CR15","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3350\/cmh.2021.0366","volume":"28","author":"MJ Goh","year":"2022","unstructured":"Goh MJ, Sinn DH. Statin and aspirin for chemoprevention of hepatocellular carcinoma: time to use or wait further? Clin Mol Hepatol. 2022;28:380\u201395. https:\/\/doi.org\/10.3350\/cmh.2021.0366.","journal-title":"Clin Mol Hepatol"},{"key":"4499_CR16","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1056\/NEJMc2009497","volume":"382","author":"Association between aspirin and hepatocellular carcinoma","year":"2020","unstructured":"Association between aspirin and hepatocellular carcinoma. N Engl J Med. 2020;382:2480\u20132. https:\/\/doi.org\/10.1056\/NEJMc2009497.","journal-title":"N Engl J Med"},{"key":"4499_CR17","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMoa1912035","volume":"382","author":"TG Simon","year":"2020","unstructured":"Simon TG, Duberg A-S, Aleman S, Chung RT, Chan AT, Ludvigsson JF. Association of aspirin with hepatocellular carcinoma and liver-related mortality. N Engl J Med. 2020;382:1018\u201328. https:\/\/doi.org\/10.1056\/NEJMoa1912035.","journal-title":"N Engl J Med"},{"key":"4499_CR18","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/hep.32380","volume":"76","author":"H Jang","year":"2022","unstructured":"Jang H, Lee YB, Moon H, Chung J, Nam JY, Cho EJ, et al. Aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B with or without cirrhosis. Hepatology. 2022;76:492\u2013501. https:\/\/doi.org\/10.1002\/hep.32380.","journal-title":"Hepatology"},{"key":"4499_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/hep4.1640","volume":"5","author":"ZN Memel","year":"2021","unstructured":"Memel ZN, Arvind A, Moninuola O, Philpotts L, Chung RT, Corey KE, et al. Aspirin use is associated with a reduced incidence of hepatocellular carcinoma: a systematic review and meta-analysis. Hepatol Commun. 2021;5:133\u201343. https:\/\/doi.org\/10.1002\/hep4.1640.","journal-title":"Hepatol Commun"},{"key":"4499_CR20","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1016\/j.cgh.2019.04.061","volume":"17","author":"TG Simon","year":"2019","unstructured":"Simon TG, Henson J, Osganian S, Masia R, Chan AT, Chung RT, et al. Daily aspirin use associated with reduced risk for fibrosis progression in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2019;17:2776-2784.e4. https:\/\/doi.org\/10.1016\/j.cgh.2019.04.061.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4499_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13870","volume":"53","author":"Q Lai","year":"2023","unstructured":"Lai Q, De Matthaeis N, Finotti M, Galati G, Marrone G, Melandro F, et al. The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma. Eur J Clin Invest. 2023;53:e13870. https:\/\/doi.org\/10.1111\/eci.13870.","journal-title":"Eur J Clin Invest"},{"key":"4499_CR22","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1080\/17474086.2022.2144217","volume":"15","author":"V La Mura","year":"2022","unstructured":"La Mura V, Bitto N, Tripodi A. Rational hemostatic management in cirrhosis: from old paradigms to new clinical challenges. Expert Rev Hematol. 2022;15:1031\u201344. https:\/\/doi.org\/10.1080\/17474086.2022.2144217.","journal-title":"Expert Rev Hematol"},{"key":"4499_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223380","volume":"14","author":"VC-C Wu","year":"2019","unstructured":"Wu VC-C, Chen S-W, Chou A-H, Ting P-C, Chang C-H, Wu M, et al. Dual antiplatelet therapy in patients with cirrhosis and acute myocardial infarction \u2013 a 13-year nationwide cohort study. PLoS One. 2019;14:e0223380. https:\/\/doi.org\/10.1371\/journal.pone.0223380.","journal-title":"PLoS One"},{"key":"4499_CR24","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/lt.25067","volume":"24","author":"SS Patel","year":"2018","unstructured":"Patel SS, Guzman LA, Lin F, Pence T, Reichman T, John B, et al. Utilization of aspirin and statin in management of coronary artery disease in patients with cirrhosis undergoing liver transplant evaluation. Liver Transpl. 2018;24:872\u201380. https:\/\/doi.org\/10.1002\/lt.25067.","journal-title":"Liver Transpl"},{"key":"4499_CR25","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1007\/s12072-022-10330-x","volume":"16","author":"LL Seifert","year":"2022","unstructured":"Seifert LL, Schindler P, Sturm L, Gu W, Seifert QE, Weller JF, et al. Aspirin improves transplant-free survival after TIPS implantation in patients with refractory ascites: a retrospective multicentre cohort study. Hepatol Int. 2022;16:658\u201368. https:\/\/doi.org\/10.1007\/s12072-022-10330-x.","journal-title":"Hepatol Int"},{"key":"4499_CR26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/apt.14121","volume":"46","author":"T Krill","year":"2017","unstructured":"Krill T, Brown G, Weideman RA, Cipher DJ, Spechler SJ, Brilakis E, et al. Patients with cirrhosis who have coronary artery disease treated with cardiac stents have high rates of gastrointestinal bleeding, but no increased mortality. Aliment Pharmacol Ther. 2017;46:183\u201392. https:\/\/doi.org\/10.1111\/apt.14121.","journal-title":"Aliment Pharmacol Ther"},{"key":"4499_CR27","doi-asserted-by":"publisher","first-page":"1514392","DOI":"10.3389\/fphar.2025.1514392","volume":"16","author":"J Wang","year":"2025","unstructured":"Wang J, Hu X, Cao S, Zhao Y, Chen M, Hua T, et al. Aspirin is associated with improved 30-day mortality in patients with sepsis-associated liver injury: a retrospective cohort study based on MIMIC IV database. Front Pharmacol. 2025;16:1514392. https:\/\/doi.org\/10.3389\/fphar.2025.1514392.","journal-title":"Front Pharmacol"},{"key":"4499_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4234061","volume":"2016","author":"S Li","year":"2016","unstructured":"Li S, Hong M, Tan H-Y, Wang N, Feng Y. Insights into the role and interdependence of oxidative stress and inflammation in liver diseases. Oxid Med Cell Longev. 2016;2016:4234061. https:\/\/doi.org\/10.1155\/2016\/4234061.","journal-title":"Oxid Med Cell Longev"},{"key":"4499_CR29","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0168-8278(03)00347-7","volume":"39","author":"M Graupera","year":"2003","unstructured":"Graupera M, Garc\u0131\u0301a-Pag\u00e1n J-C, Par\u00e9s M, Abraldes JG, Rosell\u00f3 J, Bosch J, et al. Cyclooxygenase-1 inhibition corrects endothelial dysfunction in cirrhotic rat livers. J Hepatol. 2003;39:515\u201321. https:\/\/doi.org\/10.1016\/S0168-8278(03)00347-7.","journal-title":"J Hepatol"},{"key":"4499_CR30","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1172\/JCI121985","volume":"129","author":"S Lucotti","year":"2019","unstructured":"Lucotti S, Cerutti C, Soyer M, Gil-Bernab\u00e9 AM, Gomes AL, Allen PD, et al. Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1\/thromboxane A2. J Clin Invest. 2019;129:1845\u201362. https:\/\/doi.org\/10.1172\/JCI121985.","journal-title":"J Clin Invest"},{"key":"4499_CR31","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41401-018-0014-x","volume":"40","author":"Y Liu","year":"2019","unstructured":"Liu Y, Feng J, Sun M, Liu B, Yang G, Bu Y, et al. Aspirin inhibits the proliferation of hepatoma cells through controlling GLUT1-mediated glucose metabolism. Acta Pharmacol Sin. 2019;40:122\u201332. https:\/\/doi.org\/10.1038\/s41401-018-0014-x.","journal-title":"Acta Pharmacol Sin"},{"key":"4499_CR32","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.3390\/cancers15112946","volume":"15","author":"C-H Lee","year":"2023","unstructured":"Lee C-H, Hsu C-Y, Yen T-H, Wu T-H, Yu M-C, Hsieh S-Y. Daily aspirin reduced the incidence of hepatocellular carcinoma and overall mortality in patients with cirrhosis. Cancers. 2023;15:2946. https:\/\/doi.org\/10.3390\/cancers15112946.","journal-title":"Cancers"},{"key":"4499_CR33","doi-asserted-by":"publisher","first-page":"S237","DOI":"10.1016\/S0168-8278(24)00914-0","volume":"80","author":"R Tzadok","year":"2024","unstructured":"Tzadok R, Bar N, Grupper A, Feigin E, Katchman H. FRI-136 aspirin reduces risk of Ascites and encephalopathy in cirrhotic patients without increasing the risk of Gastrointestinal bleeding. J Hepatol. 2024;80:S237. https:\/\/doi.org\/10.1016\/S0168-8278(24)00914-0.","journal-title":"J Hepatol"},{"key":"4499_CR34","doi-asserted-by":"publisher","first-page":"S1431","DOI":"10.14309\/01.ajg.0001037372.00517.29","volume":"119","author":"AK Patel","year":"2024","unstructured":"Patel AK, Fazir A, Cooper K, Devuni D. S2001 effect of aspirin and Statin on liver markers and mortality in patients with cirrhosis. Off J Am Coll Gastroenterol| ACG. 2024;119:S1431\u20132.","journal-title":"Off J Am Coll Gastroenterol| ACG"},{"key":"4499_CR35","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.3390\/cancers15133518","volume":"15","author":"J Abdelmalak","year":"2023","unstructured":"Abdelmalak J, Tan N, Con D, Eslick G, Majeed A, Kemp W, et al. The effect of aspirin use on incident hepatocellular carcinoma\u2014an updated systematic review and meta-analysis. Cancers. 2023;15:3518. https:\/\/doi.org\/10.3390\/cancers15133518.","journal-title":"Cancers"},{"key":"4499_CR36","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.3390\/diagnostics13213362","volume":"13","author":"M Cazzola","year":"2023","unstructured":"Cazzola M, Rogliani P, Ora J, Calzetta L, Lauro D, Matera MG. Hyperglycaemia and chronic obstructive pulmonary disease. Diagnostics. 2023;13:3362. https:\/\/doi.org\/10.3390\/diagnostics13213362.","journal-title":"Diagnostics"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04499-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04499-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04499-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T14:23:35Z","timestamp":1767882215000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-025-04499-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4499"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04499-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7556874\/v1","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"7 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}